InSightec ExAblate Panel To Consider International Uterine Fibroid Data
This article was originally published in The Gray Sheet
Executive Summary
InSightec's PMA for non-invasive ExAblate 2000 treatment of uterine fibroids will be reviewed by FDA's Obstetrics & Gynecology Devices Panel June 3